ScottAvardMacDiarmidMD

PubMed

• Efficacy and safety of an alternative onabotulinumtoxinA injection paradigm for refractory overactive bladder.
  Scott MacDiarmid, David B Glazier, Rebecca J McCrery, Michael J Kennelly, Mariana Nelson, Kimberly Becker Ifantides, Kurt A McCammon> ;Neurourology and Urodynamics. 2024 Jan 1
• 1 citations
  Six-Month Outcomes of Reimplantation of a Coin-Sized Tibial Nerve Stimulator for the Treatment of Overactive Bladder Syndrome With Urgency Urinary Incontinence.
  Bilal Kaaki, Sharon English, Peter Gilling, Patrick Meffan, Vincent Lucente, Scott MacDiarmid, Matthew Clark, Subhro K Sen> ;Female Pelvic Medicine & Reconstructive Surgery. 2022 May 1
• 2 citations
  Twelve-month Durability of a Fully-implanted, Nickel-sized and Shaped Tibial Nerve Stimulator for the Treatment of Overactive Bladder Syndrome with Urgency Urinary Inc...
  Peter J. Gilling, Patrick Meffan, Bilal Kaaki, Scott MacDiarmid, Vincent Lucente, Matthew Clark, Subhro K. Sen, Sharon English, Peter K. Sand> ;Urology. 2021 May 26
• 3 citations
  Taking OAB seriously: A qualitative evaluation of primary care education on overactive bladder syndrome management.
  Wendy Turell, Alexandra Howson, Scott MacDiarmid, Matt T. Rosenberg> ;International Journal of Clinical Practice. 2020 Jul 27
• 7 citations
  A Prospective Study to Evaluate Efficacy Using the Nuro Percutaneous Tibial Neuromodulation System in Drug-Naïve Patients With Overactive Bladder Syndrome.
  Kathleen C. Kobashi, Victor W. Nitti, Eric Margolis, Peter K. Sand, Steven Siegel, Salil Khandwala, Diane K. Newman, Scott MacDiarmid, Fangyu Kan, Elizabeth Michaud> ;Urology. 2018 Apr 1
• 29 citations
  Feasibility of a Fully Implanted, Nickel Sized and Shaped Tibial Nerve Stimulator for the Treatment of Overactive Bladder Syndrome with Urgency Urinary Incontinence.
  Scott MacDiarmid, David R. Staskin, Vincent Lucente, Bilal Kaaki, Sharon English, Peter J. Gilling, Patrick Meffan, Matthew Clark, Peter K. Sand, Subhro K. Sen, Eric S...> ;The Journal of Urology. 2019 Feb 6
• 16 citations
  Efficacy and Safety of SER120 Nasal Spray in Patients with Nocturia: Pooled Analysis of 2 Randomized, Double-Blind, Placebo Controlled, Phase 3 Trials.
  Jed Kaminetsky, Seymour Fein, Roger R. Dmochowski, Scott MacDiarmid, Steven Abrams, Maria Cheng, Alan J. Wein> ;The Journal of Urology. 2018 Sep 1
• 9 citations
  Clean intermittent catheterization rates after initial and subsequent treatments with onabotulinumtoxinA for non-neurogenic overactive bladder in real-world clinical s...
  Michael Kennelly, Lonny Green, Nancy Alvandi, Salim Wehbe, John Joseph Smith, Scott MacDiarmid, Jeffrey Mangel, Marc Schwartz, Tamer Aboushwareb, Brian Murray> ;Current Medical Research and Opinion. 2018 Mar 20
• 14 citations
  A pilot feasibility study of treating overactive bladder patients with percutaneous saphenous nerve stimulation
  Scott MacDiarmid, M. Sasha John, Paul B. Yoo> ;Neurourology and Urodynamics. 2018 Jun 1
• 7 citations
  Assessing Preference-Based Outcome Measures for Overactive Bladder: An Evaluation of Patient-Reported Outcome Data from the BESIDE Clinical Trial
  M. Herdman, Jameel Nazir, Zalmai Hakimi, Emad Siddiqui, Moses Huang, Marco Pavesi, Scott MacDiarmid, Marcus J. Drake, Nancy Devlin> ;The Patient. 2017 Dec 1
• 19 citations
  Treating Overactive Bladder in Older Patients with a Combination of Mirabegron and Solifenacin: A Prespecified Analysis from the BESIDE Study
  William Gibson, Scott MacDiarmid, Moses Huang, Emad Siddiqui, Matthias Stölzel, Nurul Choudhury, Marcus J. Drake> ;European Urology Focus. 2017 Dec 1
• 16 citations
  Cardiovascular safety in refractory incontinent patients with overactive bladder receiving add-on mirabegron therapy to solifenacin (BESIDE)
  Marcus J. Drake, Scott MacDiarmid, Christopher R. Chapple, Ahmet Adil Esen, Stavros Athanasiou, Javier Cambronero Santos, David Mitcheson, Sender Herschorn, Emad Siddi...> ;International Journal of Clinical Practice. 2017 May 1
• 5 citations
  Adding Mirabegron to Solifenacin to Treat Overactive Bladder Has Little Impact on Postvoid Residual Volume or Urinary Retention Risk.
  Marcus J. Drake, Scott MacDiarmid, Salman Al-Shukri, Jack Barkin, Aino Fianu-Jonasson, Sender Herschorn, Moses Huang, Matthias Stoelzel, Emad Siddiqui> ;Urology. 2017 Mar 16
• 35 citations
  Mirabegron as Add-On Treatment to Solifenacin in Patients with Incontinent Overactive Bladder and an Inadequate Response to Solifenacin Monotherapy
  Scott MacDiarmid, Salman Al-Shukri, Jack Barkin, Aino Fianu-Jonasson, Philippe Grise, Sender Herschorn, Tahir Saleem, Moses Huang, Emad Siddiqui, Matthias Stölzel, Cla...> ;The Journal of Urology. 2016 Sep 1
• 102 citations
  Efficacy and Safety of Mirabegron Add-on Therapy to Solifenacin in Incontinent Overactive Bladder Patients With an Inadequate Response to Initial 4-Week Solifenacin Mo...
  Marcus J. Drake, Christopher R. Chapple, Ahmet Adil Esen, Stavros Athanasiou, Javier Cambronero, David Mitcheson, Sender Herschorn, Tahir Saleem, Moses Huang, Emad Sid...> ;European Urology. 2016 Jul 1
• Flexible dosing with fesoterodine 4 and 8 mg: a systematic review of data from clinical trials.
  Wyndaele JJ, Schneider T, MacDiarmid S, Scholfield D, Arumi D> ;Int. J. Clin. Pract.. 2014-07-01
• 22 citations
  Validation of a bladder symptom screening tool in women with incontinence due to overactive bladder
  Linda Cardozo, David R. Staskin, Brooke Currie, Ingela Wiklund, Manuel Signori, Roger R. Dmochowski, Scott MacDiarmid, Victor W. Nitti, Karen Noblett> ;International Urogynecology Journal. 2014 May 24
• 3 citations
  Posterior Tibial Nerve Stimulation before a Trial of Sacral Nerve Stimulation for Refractory Urge Incontinence
  Scott MacDiarmid, Steven Siegel> ;The Journal of Urology. 2014 Jun 1
• 257 citations
  OnabotulinumtoxinA 100 U Significantly Improves All Idiopathic Overactive Bladder Symptoms and Quality of Life in Patients with Overactive Bladder and Urinary Incontin...
  Christopher R. Chapple, Karl-Dietrich Sievert, Scott MacDiarmid, Vik Khullar, Piotr Radziszewski, Christopher Nardo, Catherine Thompson, J. Zhou, Cornelia Haag-Molkent...> ;European Urology. 2013 Aug 1
• 19 citations
  Development of a short form and scoring algorithm from the validated actionable bladder symptom screening tool
  David W. Bates, Jack Burks, Manuel Signori, Stacie Hudgens, P Denys, Scott MacDiarmid, Victor W. Nitti, Ib R. Odderson, Amy Perrin Ross, Michael B. Chancellor> ;BMC Neurology. 2013 Jul 9
• 59 citations
  Sustained therapeutic effects of percutaneous tibial nerve stimulation: 24‐month results of the STEP study
  Kenneth M. Peters, Donna J. Carrico, Scott MacDiarmid, Leslie Wooldridge, Ansar U. Khan, Craig E. McCoy, Nicholas Franco, Jason Bennett> ;Neurourology and Urodynamics. 2013 Jan 1
• 37 citations
  Cost of Neuromodulation Therapies for Overactive Bladder: Percutaneous Tibial Nerve Stimulation Versus Sacral Nerve Stimulation
  Melissa Martinson, Scott MacDiarmid, Edward J. Black> ;The Journal of Urology. 2013 Jan 1
• 32 citations
  Development and validation of the actionable bladder symptom screening tool for multiple sclerosis patients.
  Jack Burks, Michael B. Chancellor, David W. Bates, Pierre Denys, Scott MacDiarmid, Victor W. Nitti, Manuel Signori, Stacie Hudgens, Ib R. Odderson, Jalesh N. Panicker,...> ;International Journal of MS Care. 2013 Jan 1
• 131 citations
  Percutaneous Tibial Nerve Stimulation for the Long-Term Treatment of Overactive Bladder: 3-Year Results of the STEP Study
  Kenneth M. Peters, Donna J. Carrico, Leslie Wooldridge, Christopher J. Miller, Scott MacDiarmid> ;The Journal of Urology. 2013 Jun 1
• Cognitive effects of oxybutynin chloride topical gel in older healthy subjects: a 1-week, randomized, double-blind, placebo- and active-controlled study.
  Kay GG, Staskin DR, MacDiarmid S, McIlwain M, Dahl NV> ;Clin Drug Investig. 2012-10-01
• Join now to see all